Rheumatoid Arthritis Flashcards
1
Q
RA
A
- inflammatory chronic disease
- systemic
- progressive
- heterogenous
- complex
2
Q
Symptoms
A
More prevalent in women than men
- pain
- swelling
- tenderness
- morning stiffness
- symmetrical
3
Q
Pathophysiology
A
- Initiation and Autoimmune Response:
Genetic and Environmental Triggers: RA is influenced by genetic predispositions (e.g., HLA-DR4 and HLA-DR1 alleles) and environmental factors like smoking and infections, which may trigger an abnormal immune response.
Autoantibodies Production: The immune system mistakenly identifies components of the body as foreign, leading to the production of autoantibodies such as rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs).
Citrullination: Inflammatory processes lead to the modification of proteins through citrullination, altering their structure and making them appear foreign to the immune system. - Synovial Inflammation (Synovitis):
Inflammatory Cell Infiltration: The synovial membrane becomes infiltrated with T cells, B cells, macrophages, and dendritic cells, leading to the secretion of pro-inflammatory cytokines (e.g., TNF-α, IL-1, IL-6).
Cytokine Storm: These cytokines promote a cycle of chronic inflammation and further recruitment of immune cells, amplifying the immune response.
Angiogenesis: New blood vessels form within the synovium, supplying oxygen and nutrients to the growing mass of inflammatory tissue. - Formation of Pannus:
Pannus Development: The chronic inflammation leads to the formation of pannus, an abnormal layer of fibrovascular or granulation tissue.
Aggressive Tissue Growth: The pannus invades and erodes adjacent cartilage and bone due to the activity of osteoclasts activated by cytokines like RANKL.
Joint Destruction: This erosion damages the joint structure, leading to the loss of cartilage and bone, causing pain, deformity, and impaired function. - Chronic Joint and Systemic Effects:
Destruction of Joint Structures: Continued inflammation and pannus formation result in joint stiffness, swelling, and deformity.
Systemic Manifestations: RA is a systemic disease, so it can involve other organs, leading to complications such as rheumatoid nodules, vasculitis, lung disease, and an increased risk of cardiovascular disease.
Fatigue and Anemia: Chronic inflammation can result in systemic effects such as fatigue and anemia of chronic disease due to the ongoing production of inflammatory cytokines. - Progression and Remission:
Flare-ups and Remissions: RA often follows a pattern of flares and remissions, where periods of increased symptoms alternate with times of reduced activity.
Joint Deformities: Over time, without effective treatment, permanent joint deformities and disability can develop.
Summary of Key Pathological Features:
Immune dysregulation: T cells, B cells, and cytokines play critical roles.
Chronic inflammation: Synovitis leading to pannus formation.
Joint destruction: Cartilage and bone erosion.
Systemic impact: Beyond joints, RA affects other organ systems.
Treatment of RA focuses on reducing inflammation, slowing disease progression, and managing symptoms through disease-modifying antirheumatic drugs (DMARDs), biologics targeting specific immune mediators, and anti-inflammatory agents.
4
Q
Early RA
A
- mild swelling of the metacarpophalangeal joints and proximal interphalangeal joints
5
Q
Established RA
A
- deformities including subluxation at the metacarpophalangeal joints, deformities of several fingers and a deformity of the thumb
6
Q
Extraarticular symptoms
A
- general sense of being unwell
- fibromyalgia
- rheumatoid nodules
- rheumatoid vasculitis
- rheumatoid lung disease
- CVD
7
Q
Diagnosis
A
- clinical history
- blood tests
- x-rays/ MRI
8
Q
Risk Factors
A
- sex
- genetic background
- infections
- epigenetics
- smoking
- dust inhalation
- microbiota
-obesity - mortality